Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease

被引：13

作者：

Dubinsky, Marla Cindy ^{[1
]}

机构：

[1] Cedars Sinai Med Ctr, Dept Pediat, Pediat IBD Ctr, Los Angeles, CA 90048 USA

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2010年 / 16卷 / 21期

关键词：

Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Perinuclear anti-neutrophil antibody; Anti-Saccharomyces cerevisiae antibody; Pouchitis; Internal penetrating; Fibrostenosing; C-REACTIVE PROTEIN; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; POUCH-ANAL ANASTOMOSIS; ULCERATIVE-COLITIS PATIENTS; CROHNS-DISEASE; FECAL CALPROTECTIN; CARDIOVASCULAR-DISEASE; NOD2/CARD15; GENOTYPE; MICROBIAL ANTIGENS; CROSS-REACTIVITY;

D O I：

10.3748/wjg.v16.i21.2604

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The search for biologic markers that can assess the natural history and perhaps predict the course of individual's disease including response to treatments over time has become an important focus of inflammatory bowel disease research. The knowledge of an individual's prognosis can help physicians and patients make important management decisions and aid communication on risk and benefits of disease and treatment. (C) 2010 Baishideng. All rights reserved.

引用

页码：2604 / 2608

页数：5

共 50 条

[1] Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients [J].

Amre, DK ;

Lu, SE ;

Costea, F ;

Seidman, EG .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (03) :645-652

[2] Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype [J].

Arnott, IDR ;

Landers, CJ ;

Nimmo, EJ ;

Drummond, HE ;

Smith, BKR ;

Targan, SR ;

Satsangi, J .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2376-2384

[3]

BATAILLE R, 1992, BLOOD, V80, P733

[4] THE CLINICAL-SIGNIFICANCE OF SERUM C REACTIVE PROTEIN-LEVELS IN CROHNS-DISEASE - RESULTS OF A PROSPECTIVE LONGITUDINAL-STUDY [J].

BOIRIVANT, M ;

LEONI, M ;

TARICIOTTI, D ;

FAIS, S ;

SQUARCIA, O ;

PALLONE, F .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 (04) :401-405

[5] Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease [J].

Bunn, SK ;

Bisset, WM ;

Main, MJC ;

Golden, BE .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 32 (02) :171-177

[6] Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels [J].

Carlson, CS ;

Aldred, SF ;

Lee, PK ;

Tracy, RP ;

Schwartz, SM ;

Rieder, M ;

Liu, KA ;

Williams, OD ;

Iribarren, C ;

Lewis, EC ;

Fornage, M ;

Boerwinkle, E ;

Gross, M ;

Jaquish, C ;

Nickerson, DA ;

Myers, RM ;

Siscovick, DS ;

Reiner, AP .

AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (01) :64-77

[7] Colonic bacteria express an ulcerative colitis pANCA-related protein epitope [J].

Cohavy, O ;

Bruckner, D ;

Gordon, LK ;

Misra, R ;

Wei, B ;

Eggena, ME ;

Targan, SR ;

Braun, J .

INFECTION AND IMMUNITY, 2000, 68 (03) :1542-1548

[8]

Cohavy O, 1999, INFECT IMMUN, V67, P6510

[9]

Consigny Y, 2001, GASTROENTEROLOGY S, V20, pA53

[10] Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease [J].

Costa, F ;

Mumolo, MG ;

Ceccarelli, L ;

Bellini, M ;

Romano, MR ;

Sterpi, C ;

Ricchiuti, A ;

Marchi, S ;

Bottai, M .

GUT, 2005, 54 (03) :364-368

← 1 2 3 4 5 →